Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
Cipla
Chinese Patent Office
Federal Trade Commission
Teva
Daiichi Sankyo
Cantor Fitzgerald
Harvard Business School

Generated: April 20, 2018

DrugPatentWatch Database Preview

VALSTAR PRESERVATIVE FREE Drug Profile

« Back to Dashboard

Which patents cover Valstar Preservative Free, and what generic alternatives are available?

Valstar Preservative Free is a drug marketed by Endo Pharm and is included in one NDA.

The generic ingredient in VALSTAR PRESERVATIVE FREE is valrubicin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the valrubicin profile page.
Drug patent expirations by year for VALSTAR PRESERVATIVE FREE
Synonyms for VALSTAR PRESERVATIVE FREE
(2S-cis)-2-(1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl pentanoate
(2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester
(8S,10S)-8-Glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione 8(sup 2)-valerate
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
2-oxo-2-((2S,4S)-2,5,12-trihydroxy-4-((5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl pentanoate
2-OXO-2-[(2S,4S)-2,5,12-TRIHYDROXY-4-{[5-HYDROXY-6-METHYL-4-(2,2,2-TRIFLUOROACETAMIDO)OXAN-2-YL]OXY}-7-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDROTETRACEN-2-YL]ETHYL PENTANOATE
2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-{[5-hydroxy-6-methyl-4-(trifluoroacetamido)oxan-2-yl]oxy}-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
AB01273977-01
AC1L26EA
AD 32
Adriamycin, 14-valerate
Adriamycin, trifluoroacetyl-, 14-valerate
AKOS015895664
AN-11147
Antibiotic AD 32
C34H36F3NO13
CHEMBL20225
D07IPB
DR003512
HSDB 7288
I06-1096
LS-15286
MLS002703032
N-Trifluoroacetyladriamycin 14-valerate
N-Trifluoroacetyladriamycin-14-valerate
N-Trifluoroacetyldoxorubicin 14-valerate
NCGC00164738-02
NCI60_001970
NSC 246131
NSC-246131
NSC246131
Pentanoic acid, 2-((2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-L-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester
Pentanoic acid,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester, (2S-cis)-
PL059636
SCHEMBL1652790
Trifluoroacetyladriamycin-14-valerate
Valrubicin (USP/INN)
Valrubicin [USAN]
Valstar
Valstar (TN)
Valstar (TN) (Anthra)
Valtaxin
ZOCKGBMQLCSHFP-ZQUOIQDWSA-N

US Patents and Regulatory Information for VALSTAR PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharm VALSTAR PRESERVATIVE FREE valrubicin SOLUTION;INTRAVESICAL 020892-001 Sep 25, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
Boehringer Ingelheim
Covington
Medtronic
US Army
UBS
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.